首页> 美国卫生研究院文献>Bioinformation >Drug-likeness prediction of designed analogues of isoniazid standard targeting FabI enzyme regulation from P. falciparum
【2h】

Drug-likeness prediction of designed analogues of isoniazid standard targeting FabI enzyme regulation from P. falciparum

机译:恶性疟原虫针对FabI酶调控的异烟肼标准品设计类似物的药物相似性预测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fatty acid biosynthesis enzymes (Fab enzyme) are important targets for anti-malarial drug development. The present study describes the toxicity screening of designed novel analogues which inhibit FabI enzyme regulation, a protein with multifunctional property. New analogues were prepared using ChemDraw Ultra 10 Software and converted into 3D PDB structure format for binding studies with FabI (PDB ID: 4IGE). Further Lipinski's rule of FIVE and ADMET profiling for toxicity prediction has been performed on the designed analogues. The result shows that ISN-23 is potential analogue exhibiting inhibition at the active site of FabI enzyme with good binding features.
机译:脂肪酸生物合成酶(Fab酶)是抗疟疾药物开发的重要目标。本研究描述了设计的新颖类似物的毒性筛选,这些类似物可抑制具有多功能特性的FabI酶调节。使用ChemDraw Ultra 10软件制备了新的类似物,并将其转换为3D PDB结构格式,以便与FabI(PDB ID:4IGE)进行结合研究。 Lipinski关于毒性预测的FIVE和ADMET分析的规则已在设计的类似物上进行。结果表明,ISN-23是潜在的类似物,在具有良好结合特性的FabI酶的活性位点表现出抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号